Kenvue Inc. (NYSE:KVUE – Get Free Report) declared a quarterly dividend on Wednesday, April 29th. Stockholders of record on Wednesday, May 13th will be paid a dividend of 0.2075 per share on Wednesday, May 27th. This represents a c) dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend is Wednesday, May 13th.
Kenvue has a dividend payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 67.5%.
Kenvue Stock Down 0.0%
Shares of NYSE KVUE opened at $17.59 on Monday. The company has a market capitalization of $33.76 billion, a P/E ratio of 20.69, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. Kenvue has a 52-week low of $14.02 and a 52-week high of $24.61. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The company’s 50 day moving average price is $17.65 and its 200-day moving average price is $17.24.
Institutional Trading of Kenvue
Hedge funds have recently modified their holdings of the stock. NBT Bank N A NY increased its stake in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC increased its stake in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares in the last quarter. Physician Wealth Advisors Inc. increased its stake in shares of Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares in the last quarter. Elyxium Wealth LLC bought a new stake in shares of Kenvue in the 4th quarter valued at $26,000. Finally, MV Capital Management Inc. bought a new stake in shares of Kenvue in the 4th quarter valued at $28,000. Institutional investors own 97.64% of the company’s stock.
About Kenvue
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
See Also
- Five stocks we like better than Kenvue
- 3 Companies Quietly Essential to Data Center and AI Operations
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
